Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Immunol ; 205(1): 202-212, 2020 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-32482710

RESUMEN

IgA nephropathy (IgAN), the most common primary glomerular disorder, has a relatively poor prognosis yet lacks a pathogenesis-based treatment. Compound K (CK) is a major absorbable intestinal bacterial metabolite of ginsenosides, which are bioactive components of ginseng. The present study revealed promising therapeutic effects of CK in two complementary IgAN models: a passively induced one developed by repeated injections of IgA immune complexes and a spontaneously occurring model of spontaneous grouped ddY mice. The potential mechanism for CK includes 1) inhibiting the activation of NLRP3 inflammasome in renal tissues, macrophages and bone marrow-derived dendritic cells, 2) enhancing the induction of autophagy through increased SIRT1 expression, and 3) eliciting autophagy-mediated NLRP3 inflammasome inhibition. The results support CK as a drug candidate for IgAN.


Asunto(s)
Autofagia/efectos de los fármacos , Ginsenósidos/farmacología , Glomerulonefritis por IGA/tratamiento farmacológico , Inflamasomas/antagonistas & inhibidores , Sirtuina 1/metabolismo , Animales , Autofagia/inmunología , Línea Celular , Células Dendríticas/efectos de los fármacos , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Modelos Animales de Enfermedad , Ginsenósidos/uso terapéutico , Glomerulonefritis por IGA/inmunología , Glomerulonefritis por IGA/patología , Humanos , Inflamasomas/inmunología , Inflamasomas/metabolismo , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/inmunología , Glomérulos Renales/patología , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Ratones Endogámicos , FN-kappa B/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Cultivo Primario de Células , Transducción de Señal/efectos de los fármacos , Transducción de Señal/inmunología
2.
Trials ; 21(1): 31, 2020 Jan 06.
Artículo en Inglés | MEDLINE | ID: mdl-31907076

RESUMEN

BACKGROUND: IgA nephropathy (IgAN) is the most common glomerular disease worldwide. It has a high incidence in Asians and is more likely to progress to end-stage renal disease (ESRD). For high-risk IgAN, which is clinically characterized by massive proteinuria and renal dysfunction, however, there has been no international consensus on treatment options. Compared with other developed countries, IgAN patients in China are often found to have severe kidney function loss at initial diagnosis. Yi-Qi-Qing-Jie formula (YQF; a compound recipe of Chinese medicinal herbs) has shown potential renal protection in our previous clinical studies. To further confirm the efficacy and safety of YQF in the treatment of high-risk IgAN, we have designed a prospective double-blind randomized placebo-controlled trial. METHODS/DESIGN: The TCM-WINE study is a single-center, prospective, double-blind randomized placebo-controlled trial. We plan to randomize 60 participants with biopsy-proven IgAN to a YQF combined group (YQF compound combined with prednisolone, and cyclophosphamide if necessary) or an immunosuppression group (placebo-YQF combined with prednisolone, and cyclophosphamide if necessary). The two groups will enter a 48-week in-trial treatment phase and receive post-trial follow-up until study completion (3 years). All patients will receive optimal supportive care. The primary composite outcome is defined as the first occurrence of a 40% decrease in estimated glomerular filtration rate (eGFR) from the baseline lasting for 3 months, initiating continuous renal replacement treatment, or death due to chronic kidney disease (CKD) during the 3-year study phase. The secondary endpoint events are defined as the mean annual eGFR decline rate (eGFR slope, ml/min per 1.73 m2 per year), which is calculated by the eGFR regression curve for each eligible patient, and proteinuria remission (prescribed as proteinuria < 0.5 g/day) at weeks 24, 36, and 48 during the in-trial phase. The remission rate of symptoms and inflammation status will be evaluated at week 48. Safety monitoring and assessment will be undertaken during the study. DISCUSSION: The TCM-WINE study will evaluate the effects and safety of YQF combined therapy compared with immunosuppression monotherapy on the basis of the optimal supportive treatment in high-risk IgAN. The evidence from this study will provide a novel, effective, and safe Chinese characteristic therapy for high-risk IgAN patients. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03418779. Registered on 18 June 2018.


Asunto(s)
Medicamentos Herbarios Chinos/administración & dosificación , Glomerulonefritis por IGA/tratamiento farmacológico , Inmunosupresores/administración & dosificación , Fallo Renal Crónico/epidemiología , Adolescente , Adulto , Anciano , China/epidemiología , Ensayos Clínicos Fase II como Asunto , Ensayos Clínicos Fase III como Asunto , Progresión de la Enfermedad , Método Doble Ciego , Quimioterapia Combinada/efectos adversos , Quimioterapia Combinada/métodos , Medicamentos Herbarios Chinos/efectos adversos , Femenino , Estudios de Seguimiento , Tasa de Filtración Glomerular/efectos de los fármacos , Glomerulonefritis por IGA/inmunología , Glomerulonefritis por IGA/mortalidad , Glomerulonefritis por IGA/patología , Humanos , Inmunosupresores/efectos adversos , Fallo Renal Crónico/inmunología , Fallo Renal Crónico/patología , Fallo Renal Crónico/terapia , Glomérulos Renales/inmunología , Glomérulos Renales/patología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Terapia de Reemplazo Renal/estadística & datos numéricos , Resultado del Tratamiento , Adulto Joven
3.
Int J Clin Exp Pathol ; 8(2): 1826-9, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25973075

RESUMEN

An eight-year-old girl, presenting with palpebral edema, gross hematuria, and foam in urine, was admitted to our hospital. Investigations indicated increased serum antistreptolysin O (ASO) and anti-mycoplasma antibody titers. Renal biopsy showed crescentic poststreptococcal acute glomerulonephritis (CPAGN) with isolated C3 deposition in the glomeruli. Electro-microscope examination showed subepithelial deposition of electron dense material. She received the double pulse therapies of methylprednisolone and cyclophosphamide as well as the treatment of oral prednisolone, angiotensin converting enzyme-II (ACE-II) inhibitor, dipyridamole and traditional Chinese medicine. The complete clinical remission was achieved after 9 months. No serious adverse effects were observed during the follow-up. Our findings indicated that CPAGN with isolated C3 deposition might have a favorable prognosis after aggressive immunosuppressive treatment. However, the influence of isolated C3 deposition on CPAGN prognosis remains to be clarified.


Asunto(s)
Complemento C3/análisis , Glomerulonefritis/inmunología , Glomérulos Renales/inmunología , Infecciones Estreptocócicas/inmunología , Enfermedad Aguda , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Biomarcadores/análisis , Biopsia , Niño , Quimioterapia Combinada , Femenino , Técnica del Anticuerpo Fluorescente , Glomerulonefritis/diagnóstico , Glomerulonefritis/tratamiento farmacológico , Humanos , Inmunosupresores/uso terapéutico , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/ultraestructura , Microscopía Electrónica , Inducción de Remisión , Infecciones Estreptocócicas/complicaciones , Infecciones Estreptocócicas/diagnóstico , Factores de Tiempo , Resultado del Tratamiento
4.
Endocrinology ; 155(12): 4939-50, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25188527

RESUMEN

Increasing evidence suggests the heterogeneity of macrophage phenotype and function ultimately determines the outcome of diabetic nephropathy (DN). This study aimed to investigate the effects of vitamin D on macrophage M1/M2 phenotype and its role in preventing podocyte impairment in streptozotocin-induced DN rats. Calcitriol, a bioactive 1,25-dihydroxyvitamin D3, ameliorated proteinuria and renal damage as well as reversed the decline of both nephrin and podocin, crucial structural proteins in podocytes. DN rats showed increased infiltrating macrophages with M1 phenotype characterized by elevated expression of inducible nitric oxide synthase and TNF-α in glomeruli and interstitium, which were inhibited after calcitriol treatment. Interestingly, calcitriol promoted M2 macrophage activation with enhanced expression of CD163, arginase-1, and mannose receptor at week 18 but not at week 8 or 14. The ratio of CD163 to CD68, considered as the proportion of M2 macrophages, was about 2.9-fold higher at week 18 after calcitriol treatment. Furthermore, the protein expression of inducible nitric oxide synthase, a crucial marker of M1 macrophages, was negatively correlated with the expression of either nephrin or podocin, whereas CD163, indicating M2 macrophages, was positively correlated. In vitro, 1,25-dihydroxyvitamin D3 switched high-glucose-induced M1 macrophages toward an M2 phenotype in either U937-derived macrophages or RAW264.7 cells. Our results suggest that vitamin D not only reduces macrophage infiltration and inhibits M1 macrophage activation but also enhances M2 macrophage phenotype to protect against podocyte injury.


Asunto(s)
Calcitriol/uso terapéutico , Nefropatías Diabéticas/prevención & control , Macrófagos/efectos de los fármacos , Podocitos/efectos de los fármacos , Vitaminas/uso terapéutico , Animales , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Glucemia/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Calcitriol/farmacología , Evaluación Preclínica de Medicamentos , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Pruebas de Función Renal , Glomérulos Renales/inmunología , Masculino , Proteínas de la Membrana/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Fenotipo , Podocitos/metabolismo , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Receptores de Superficie Celular/metabolismo , Vitaminas/farmacología
5.
Clin Exp Immunol ; 177(2): 381-90, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24666423

RESUMEN

Alpha-melanocyte stimulating hormone (α-MSH) is a neuropeptide exhibiting anti-inflammatory activity in experimental models of autoimmune diseases. However, no studies thus far have examined the effects of α-MSH on systemic lupus erythematosus (SLE). This study aimed to determine the effects of an α-MSH agonist in induced murine lupus. Here we employed female Balb/cAn mice in which lupus was induced by pristane. Groups of lupus animals were treated daily with the α-MSH analogue [Nle4, DPhe7]-α-MSH (NDP-MSH) (1·25 mg/kg) injected intraperitoneally or saline for 180 days. Normal animals comprised the control group. Arthritis incidence, plasma immunoglobulin (Ig)G isotypes, anti-nuclear antibodies (ANA) and plasma cytokines were evaluated. Renal function was assessed by proteinuria and histopathological lesion. Glomerular levels of IgG, α-smooth muscle actin (α-SMA), inducible nitric oxide synthase (iNOS), C3, CD3, melanocortin receptors (MCR)1, corticotrophin-releasing factor (CRF) and α-MSH was estimated by immunohistochemistry. When compared with normal controls, lupus animals exhibited increased arthritis, IgG levels, ANA, interleukin (IL)-6, IL-10, proteinuria and mesangial cell proliferation together with glomerular expression of α-SMA and iNOS. Glomerular expression of MCR1 was reduced in lupus animals. NDP-MSH treatment reduced arthritis scores by 70% and also diminished IgG1 and IgG2a levels and ANA incidence. In the glomerulus, NDP-MSH treatment reduced cellularity by 50% together with reducing IgG deposits, and expression levels of α-SMA, iNOS and CRF were also all decreased. Taken together, our results suggest for the first time that α-MSH treatment improves several parameters of SLE disease activity in mice, and indicate that this hormone is an interesting potential future treatment option.


Asunto(s)
Lupus Eritematoso Sistémico/metabolismo , alfa-MSH/metabolismo , Animales , Anticuerpos Antinucleares/sangre , Anticuerpos Antinucleares/inmunología , Artritis/tratamiento farmacológico , Artritis/etiología , Artritis/inmunología , Artritis/metabolismo , Hormona Liberadora de Corticotropina/metabolismo , Citocinas/biosíntesis , Modelos Animales de Enfermedad , Femenino , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/inmunología , Glomérulos Renales/metabolismo , Glomérulos Renales/patología , Lupus Eritematoso Sistémico/inducido químicamente , Lupus Eritematoso Sistémico/tratamiento farmacológico , Lupus Eritematoso Sistémico/inmunología , Ratones , Óxido Nítrico Sintasa de Tipo II/metabolismo , Receptor de Melanocortina Tipo 1/metabolismo , Terpenos/efectos adversos , alfa-MSH/administración & dosificación
6.
Br J Nutr ; 110(1): 69-76, 2013 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-23181951

RESUMEN

Curcumin has been used in Asian traditional medicine for its medicinal properties. Recent studies have demonstrated that curcumin has antioxidant, anti-tumour and anti-inflammatory activities. The aim of the present study is to investigate the effects of curcumin on established lupus nephritis (LN) in New Zealand Black/White (NZB/W) F1 female mice, in particular, its interaction with regulatory T (Treg) cells. Starting at 18 weeks of age, mice were fed a standard diet or a diet containing 1 % curcumin until the end of the study. The proteinuria level and the serum levels of IgG1, IgG2a and anti-double-stranded DNA (dsDNA) IgG antibodies were measured. Additionally, IgG immune complex deposition in the glomeruli and renal inflammation were compared between curcumin-treated mice and control mice. Curcumin decreased the proteinuria level and serum levels of IgG1, IgG2a and anti-dsDNA IgG antibodies in NZB/W F1 female mice. IgG immune complex deposition in the glomeruli was reduced in curcumin-treated mice. Furthermore, renal inflammation was also decreased after curcumin treatment. Interestingly, these therapeutic effects of curcumin disappeared after Treg depletion by anti-CD25 antibody injection. Curcumin exerted a protective effect against LN in NZB/W F1 mice. We speculate that the protective effects of curcumin in LN may involve, at least in part, its interaction with Treg cells.


Asunto(s)
Curcuma/química , Curcumina/uso terapéutico , Inmunoglobulina G/metabolismo , Glomérulos Renales/efectos de los fármacos , Nefritis Lúpica/prevención & control , Fitoterapia , Linfocitos T Reguladores/metabolismo , Animales , Anticuerpos , Anticuerpos Antinucleares/metabolismo , Complejo Antígeno-Anticuerpo/metabolismo , Curcumina/farmacología , Suplementos Dietéticos , Femenino , Subunidad alfa del Receptor de Interleucina-2/metabolismo , Glomérulos Renales/inmunología , Glomérulos Renales/metabolismo , Glomérulos Renales/patología , Nefritis Lúpica/inmunología , Nefritis Lúpica/metabolismo , Ratones , Ratones Endogámicos NZB , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Proteinuria/prevención & control
7.
J Pharmacol Sci ; 118(4): 433-46, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22447300

RESUMEN

Multi-glycoside, one of the extracted compounds from Tripterygium wilfordii HOOK. f. (GTW), has been shown to be clinically effective in suppressing glomerular inflammation in chronic kidney disease. However, its clinical application is often limited by its cytotoxic actions on the liver. This study was performed to contrast the dose-effects of GTW on glomerular inflammation and hepatic damage in two types of anti-Thy1.1 glomerulonephritis (GN). Rats with acute or chronic anti-Thy1.1 GN were either left untreated (the Vehicle group) or treated with a high or low dose of GTW and sacrificed on day 7 or day 45. GTW was administrated 3 days before or at the same time as the antibody injection and lasted until sacrifice. GTW at high dose ameliorated glomerular macrophage accumulation, mesangial proliferation, proteinuria, and interleukin-2 expression in the acute anti-Thy1.1 GN model, but caused structural and functional lesions in the liver. In contrast, GTW at low dose improved activated macrophage and T lymphocyte infiltration, mesangial injury, proteinuria, and interleukin-2 and interferon-γ expressions without hepatic toxicity in the chronic model of GN induced by anti-Thy1.1 antibody. In conclusion, GTW at low dose not only effectively inhibits glomerular inflammation but also avoids severe injuries to the liver.


Asunto(s)
Glomerulonefritis/tratamiento farmacológico , Glomerulonefritis/patología , Glicósidos/fisiología , Mediadores de Inflamación/fisiología , Isoanticuerpos/toxicidad , Hepatopatías/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Tripterygium , Animales , Relación Dosis-Respuesta Inmunológica , Femenino , Glomerulonefritis/inmunología , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/inmunología , Glomérulos Renales/patología , Hepatopatías/inmunología , Hepatopatías/patología , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Ratas , Ratas Wistar , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Linfocitos T/patología , Tripterygium/inmunología
8.
Int J Clin Exp Pathol ; 4(6): 606-15, 2011 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-21904636

RESUMEN

BACKGROUND: Growing evidence suggests that blockade of the aldosterone-receptor may preserve kidney function by anti-inflammatory effects independent of the blood pressure. We hypothesized that the selective aldosterone-receptor antagonist eplerenone has a profound anti-inflammatory effect in the autologous phase of anti-glomerular basement membrane (GBM) glomerulonephritis (GN). METHODS: Mice received ≈200mg/kg body wt/day eplerenone via supplemented chow diet or standard chow starting at the day of immunization with rabbit IgG. Three days later the anti-GBM antibody was injected and the experiments were stopped at day 7 and 14. RESULTS: Mice receiving eplerenone showed significantly decreased albuminuria and glomerular sclerosis at day 7 and 14 after induction of anti-GBM GN. Eplerenone treatment significantly inhibited the infiltration of CD4+, CD8+ T cells and macrophages into the kidneys. Circulating levels and glomerular deposition of autologous IgG were comparable in both groups. At day 7 the pro-inflammatory cytokines MCP-1 and IL-6 were found to be significantly decreased in regional draining lymph nodes of eplerenone-treated mice, whereas the anti-inflammatory cytokine IL-10 was significantly upregulated. In line, splenocytes from eplerenone-treated nephritic mice produced significantly increased IL-10. CONCLUSION: Aldosterone-receptor blockade by eplerenone effectively attenuated proteinuria, kidney damage and the inflammatory response in anti-GBM GN by significantly decreasing pro-inflammatory cytokines in the regional draining lymph nodes of the kidney. Our results suggest that this selective aldosterone receptor antagonist is a possible additional tool in the treatment of GN.


Asunto(s)
Enfermedad por Anticuerpos Antimembrana Basal Glomerular/prevención & control , Antagonistas de Receptores de Mineralocorticoides/uso terapéutico , Espironolactona/análogos & derivados , Albuminuria , Animales , Enfermedad por Anticuerpos Antimembrana Basal Glomerular/inmunología , Enfermedad por Anticuerpos Antimembrana Basal Glomerular/patología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/patología , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/patología , Citocinas/metabolismo , Eplerenona , Inmunoglobulina G/inmunología , Inmunoglobulina G/metabolismo , Glomérulos Renales/inmunología , Glomérulos Renales/patología , Ganglios Linfáticos/efectos de los fármacos , Ganglios Linfáticos/metabolismo , Masculino , Ratones , Conejos , Espironolactona/uso terapéutico , Bazo/efectos de los fármacos , Bazo/metabolismo
9.
Ann Rheum Dis ; 70(2): 356-65, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21062851

RESUMEN

OBJECTIVE: To determine whether inhibition of p38 mitogen-activated protein kinase (p38MAPK) reduces the pathogenicity of anti-neutrophil cytoplasmic autoantibodies (ANCAs) in vitro and in vivo. METHODS: The effects of the p38MAPK-specific inhibitor AR-447 were studied in vitro using neutrophil respiratory burst and degranulation assays, and in lipopolysaccharide (LPS)-stimulated human glomerular endothelial cells. In vivo, p38MAPK inhibition was investigated in a mouse anti-myeloperoxidase (MPO) IgG/LPS glomerulonephritis model. Mice were treated orally with AR-447 daily, starting before (pretreatment group) or 24 h after disease onset (treatment group), and killed after 1 or 7 day(s). RESULTS: In vitro, AR-447 diminished neutrophil respiratory burst and degranulation induced by patient-derived MPO-ANCA and proteinase 3 (Pr3)-ANCA. In glomerular endothelial cells, AR-447 reduced LPS-induced secretion of IL-6 and IL-8, but not of MCP-1. In mice, pretreatment with AR-447 reduced albuminuria 1 day after induction of glomerulonephritis. After 7 days, no effects on urinary abnormalities were observed upon AR-447 pretreatment or treatment. Also, glomerular neutrophil accumulation was not diminished. In contrast, glomerular macrophage accumulation and the formation of glomerular crescents was significantly reduced by AR-447 pretreatment (vehicle: 12.5 ± 5.6% crescentic glomeruli; AR-447: 7.7 ± 2.7%) and treatment (vehicle 14.6 ± 1.8%; AR-447 6.0 ± 3.4%) at 7 days. CONCLUSION: This study shows that p38MAPK inhibition markedly reduces ANCA-induced neutrophil activation in vitro. In vivo, p38MAPK inhibition partly reduced crescent formation when the drug was administered prior to disease induction and after disease onset, suggesting that besides p38MAPK activity other signalling pathways contribute to the disease activity.


Asunto(s)
Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/prevención & control , Anticuerpos Anticitoplasma de Neutrófilos/inmunología , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores , Animales , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/enzimología , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/inmunología , Células Cultivadas , Citocinas/biosíntesis , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos/métodos , Femenino , Glomerulonefritis/enzimología , Glomerulonefritis/inmunología , Glomerulonefritis/prevención & control , Humanos , Inmunoglobulina G/inmunología , Glomérulos Renales/inmunología , Lipopolisacáridos/inmunología , Sistema de Señalización de MAP Quinasas/fisiología , Ratones , Ratones Noqueados , Activación Neutrófila/inmunología , Peroxidasa/inmunología , Inhibidores de Proteínas Quinasas/uso terapéutico , Estallido Respiratorio/inmunología , Proteínas Quinasas p38 Activadas por Mitógenos/fisiología
10.
Transplantation ; 83(5): 656-62, 2007 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-17353790

RESUMEN

Hematopoietic growth factors (HGF) mobilize potential tolerogenic cells in transplant donors. Fms-like tyrosine kinase 3 ligand (Flt3L) mobilizes stem cells and dendritic cells (DCs) in human and nonhuman primate blood. Blood and renal and liver biopsies were obtained from untreated and Flt3L-mobilized rhesus macaques. Flt3L increased the number of myeloid CD11c(hi) and plasmacytoid CD123(hi) precursors in blood and both myeloid CD11c(+) HLA-DR(+) fascin(+) (CD45RA(-)) DCs and putative plasmacytoid CD11c(lo) CD45RA(hi) DC precursors in liver and kidneys, without affecting organ function. DC in Flt3L-treated monkeys were concentrated in the glomeruli and interstitium of kidneys, and in the portal triads and parenchyma of liver. These DCs exhibited the phenotype of immature antigen-presenting cells (APCs; CD83(-) CD86(lo) CCR5(+) CCR7(-)). HGF-induced changes reversed significantly within 7 days of Flt3L withdrawal. Therapeutic protocols that mobilize donor hematopoietic cells should consider the influence of HGF on the APC constituency of prospective organ allografts.


Asunto(s)
Células Dendríticas/inmunología , Sustancias de Crecimiento/farmacología , Trasplante de Riñón/inmunología , Trasplante de Hígado/inmunología , Adyuvantes Inmunológicos/uso terapéutico , Animales , Terapia Biológica , Células Dendríticas/patología , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/inmunología , Glomérulos Renales/patología , Trasplante de Riñón/patología , Trasplante de Hígado/patología , Macaca mulatta , Proteínas de la Membrana/uso terapéutico , Modelos Animales
11.
Lupus ; 16(1): 18-24, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17283580

RESUMEN

Renal involvement in systemic lupus erythematosus is a common complication that significantly worsens morbidity and mortality. Although treatment with corticosteroids and cytotoxic drugs may be useful in many cases, morbidity associated with these drugs and the relapsing nature of the disease make it necessary to develop new treatment strategies. Five-month old female NZB/W F1 mice were divided into the following groups: CYP group (n = 10), cyclophosphamide (CYP) 50 mg/kg intraperitoneally every 10 days; RAPA 1 group (n = 10) oral daily sirolimus (SRL), 1 mg/kg; RAPA 12 group (n = 13), oral daily SRL, 12mg/kg; FTY group (n = 10), oral fingolimod (FTY720), 2 mg/kg three times per week. An additional group of 13 non-treated mice were used as a control (control group). Follow-up was performed over four months. Animal survival, body weight, anti-DNA antibodies and proteinuria were determined. Kidneys were processed for conventional histology and immunofluorescence for IgG and complement. Total histological score (HS) was the sum of mesangial expansion, endocapillary proliferation glomerular deposits, extracapillary proliferation, interstitial infiltrates, tubular atrophy and interstitial fibrosis. All treated groups had lower proteinuria at the end of the follow-up with respect to the control group (P < 0.0001). Serum anti-DNA antibodies were appropriately controlled in RAPA 1 and CYP groups, but not in FTY or RAPA 12 groups. SRL and CYP arrested, and perhaps reversed almost all histological lesions. FTY720 ameliorated histological lesions but did not control mesangial expansion or interstitial infiltrates. SRL produces great improvement in murine lupus nephritis, while FTY720 seems a promising alternative if used in appropriate doses.


Asunto(s)
Inmunosupresores/uso terapéutico , Nefritis Lúpica/tratamiento farmacológico , Glicoles de Propileno/uso terapéutico , Sirolimus/uso terapéutico , Esfingosina/análogos & derivados , Administración Oral , Animales , Anticuerpos Antinucleares/sangre , Apoptosis/inmunología , Autoantígenos/inmunología , Movimiento Celular/efectos de los fármacos , Cromatina/inmunología , Complemento C3/análisis , Factor Nefrítico del Complemento 3/análisis , Ciclofosfamida/administración & dosificación , Ciclofosfamida/uso terapéutico , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Femenino , Clorhidrato de Fingolimod , Mesangio Glomerular/patología , Inmunoglobulina G/análisis , Inmunosupresores/farmacología , Inyecciones Intraperitoneales , Glomérulos Renales/inmunología , Glomérulos Renales/patología , Nefritis Lúpica/genética , Nefritis Lúpica/inmunología , Nefritis Lúpica/patología , Linfocitos/efectos de los fármacos , Ratones , Ratones Endogámicos NZB , Nucleosomas/inmunología , Glicoles de Propileno/administración & dosificación , Glicoles de Propileno/farmacología , Proteinuria/etiología , Receptores de Lisoesfingolípidos/efectos de los fármacos , Sirolimus/administración & dosificación , Sirolimus/farmacología , Esfingosina/administración & dosificación , Esfingosina/farmacología , Esfingosina/uso terapéutico
12.
Biol Pharm Bull ; 28(11): 2170-2, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16272714

RESUMEN

The pharmacokinetics of panipenem in experimental renal failure animal models was investigated in order to identify the appropriate covariates affecting the pharmacokinetic behavior. Panipenem and betamipron were administered intravenously to rats with a variety of renal failures, such as nephritis induced by glycerol, gentamicin, uranium and antiserum against glomerular basement membrane as well as 5/6 subtotal nephrectomy. Panipenem in plasma and urine was determined and pharmacokinetic analysis was performed using a one-compartment open model. The elimination half-life prolonged and total body clearance, renal clearance (CL(R)) and renal excretion ratio were decreased according to the renal function, i.e. control>glycerol>anti-GBM=gentamicin>nephrectomy=uranium in order. However, distribution volume was consistent in all models. CL(R) showed strong positive correlation with the glomerular filtration rate in spite of a weak correlation with the reciprocal of blood urea nitrogen. However, no obvious correlation was observed with secretory clearance of N-1-methylnicotinamide. This preliminary information based on animal model might be useful for designing pharmacokinetic studies in special population at early stage of new drug development.


Asunto(s)
Insuficiencia Renal/metabolismo , Tienamicinas/farmacocinética , Animales , Antibacterianos , Área Bajo la Curva , Autoanticuerpos , Membrana Basal/inmunología , Nitrógeno de la Urea Sanguínea , Cromatografía Líquida de Alta Presión , Gentamicinas , Tasa de Filtración Glomerular , Glicerol , Semivida , Pruebas de Función Renal , Glomérulos Renales/inmunología , Masculino , Nefritis/inducido químicamente , Nefritis/metabolismo , Ratas , Ratas Wistar , Insuficiencia Renal/inducido químicamente , Insuficiencia Renal/fisiopatología , Espectrofotometría Ultravioleta , Distribución Tisular , Uranio
13.
Am J Chin Med ; 33(4): 613-26, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16173535

RESUMEN

IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide, yet there is no effective or specific therapy. Shen San Fang (S3F) is a traditional Chinese herbal medicinal formula that has been used in China for many years to treat patients with hematuria. The aim of this study is to test the therapeutic value of S3F in an experimental model of IgAN. IgAN was induced in Lewis rats by continuous oral immunization with bovine gamma-globulin (BGG) in the drinking water for 8 weeks, followed by intravenous injection of 1 mg BGG daily for 3 successive days. The rats were randomly divided into four groups (five rats/group): control, control receiving S3F, induction of IgAN, and IgAN receiving S3E S3F decoction was fed to rats beginning week 4 from the first day of oral sensitization with BGG. The S3F treatment was continued until the rats were sacrificed or for a 4-week period. Hematuria, renal immunohistochemistry for IgA and transforming growth factor-beta 1 (TGF-beta1), renal histopathology, and renal content of TGF-beta1 were measured. Rats developing IgAN had marked hematuria, profound mesangial proliferation and mesangial expansion, intense and diffuse glomerular IgA deposition, increased glomerular TGF-beta1 expression, and raised renal TGF-beta1 levels. S3F treatment resulted in a significant reduction of hematuria, decreased mesangial IgA deposition, weaker immunostaining of TGF-beta1 in glomerulus, and a lower renal TGF-beta1 concentration. Our animal data suggests a therapeutic value for the Chinese medicinal formula S3F in experimental IgAN. This beneficial effect was due to reduced glomerular IgA deposition and TGF-beta1 expression. Our preliminary findings hold promise for future human therapy.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Glomerulonefritis por IGA/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Glomerulonefritis por IGA/inmunología , Glomerulonefritis por IGA/patología , Hematuria/tratamiento farmacológico , Inmunización , Inmunohistoquímica , Glomérulos Renales/inmunología , Glomérulos Renales/metabolismo , Glomérulos Renales/patología , Masculino , Ratas , Ratas Endogámicas Lew , Factor de Crecimiento Transformador beta/metabolismo , Factor de Crecimiento Transformador beta1 , Urinálisis , gammaglobulinas/inmunología
14.
Kidney Int ; 66(3): 1018-28, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15327395

RESUMEN

BACKGROUND: Retinoic acid (tRA) is an active metabolite of vitamin A with potent anti-inflammatory properties. We analyzed the effects of tRA on the development of lupus nephritis in MRL/lpr mice. METHODS: MRL/lpr mice received chow supplemented with vehicle or tRA (daily 10 mg/kg) from 8 to 14 weeks until their sacrifice. MRL/wt mice served as an additional control. RESULTS: tRA-treated MRL/lpr mice showed reduced lymphoadenopathy and splenomegaly as compared to vehicle-treated controls. Treatment reduced proteinuria to almost basal levels. Plasma IgG and anti-DNA antibodies increased comparably in both vehicle and tRA-treated mice. Vehicle-treated mice showed characteristic renal lesions. In contrast tRA-treated mice showed almost normal glomerular histology with a pronounced reduction in endocapillary cell proliferation. T-cell and macrophage infiltrates were reduced after tRA treatment within glomeruli and interstitium as compared to vehicle-treated animals. In spite of this, immune complex and complement deposition were comparable in both groups. Adoptively transferred T cells from vehicle-treated to tRA-treated MRL/lpr mice did not induce renal lesions or proteinuria. These beneficial effects of tRA treatment were associated with reduced renal expression of chemokines and inflammatory cytokines. Surprisingly, renal transforming growth factor-beta (TGF-beta) mRNA levels of tRA-treated mice were elevated, possibly indicating that TGF-beta acts as an anti-inflammatory signal in this lupus model. CONCLUSION: tRA treatment reduces lymphoproliferation and glomerulonephritis in MRL/lpr mice. This occurs in spite of unaltered anti-DNA titers and glomerular immune complex deposition, and cannot be overcome by T-cell transfer from nephritic MRL/lpr mice.


Asunto(s)
Antineoplásicos/farmacología , Nefritis Lúpica/tratamiento farmacológico , Nefritis Lúpica/prevención & control , Tretinoina/farmacología , Traslado Adoptivo , Animales , Peso Corporal , Quimiocinas/genética , Citocinas/genética , Inmunoglobulina G/sangre , Glomérulos Renales/efectos de los fármacos , Glomérulos Renales/inmunología , Glomérulos Renales/patología , Nefritis Lúpica/inmunología , Nefritis Lúpica/patología , Macrófagos/citología , Ratones , Ratones Endogámicos MRL lpr , Tamaño de los Órganos , ARN Mensajero/análisis , Linfocitos T/citología
15.
Pathol Int ; 51(2): 72-81, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11169144

RESUMEN

It has been observed that with Masugi nephritis in Wistar rats the initiation of endocapillary proliferative changes with macrophage accumulation is usually followed by glomerular sclerosis without extracapillary extension. In the present study, the provocation of an extracapillary lesion was attempted using accelerated Masugi nephritis in Wistar-Kyoto rats. In order to accelerate the accumulation of monocyte/macrophages, the administration of methylcellulose was added in an additional group. The development and fate of extracapillary lesions were analyzed histopathologically and immunohistochemically. As a result, the formation of extracapillary proliferation of granulomatous lesions could be initiated in this model. Granulomatous lesions were composed of CD4+ T cells and CD8+ T cells and monocyte/macrophages including multinucleated giant cells. These inflammatory cells had seemingly escaped from the capillary lumen through the injured glomerular basement membrane and formed cellular and granulomatous crescents. In addition, tenascin was strongly expressed in cellular crescents and was a unique extracellular matrix at this cellular stage. The cellular crescents then progressed to sclerosis with the formation of increased collagenous extracellular matrix. These results suggest that a delayed-type hypersensitivity plays a role in granulomatous crescent formation, even though the initial glomerular injury was evoked by a humoral antibody.


Asunto(s)
Enfermedad por Anticuerpos Antimembrana Basal Glomerular/patología , Granuloma/patología , Glomérulos Renales/patología , Animales , Enfermedad por Anticuerpos Antimembrana Basal Glomerular/inmunología , Enfermedad por Anticuerpos Antimembrana Basal Glomerular/metabolismo , Enfermedad por Anticuerpos Antimembrana Basal Glomerular/fisiopatología , Membrana Basal/inmunología , Linfocitos T CD4-Positivos/patología , Linfocitos T CD8-positivos/patología , Modelos Animales de Enfermedad , Adyuvante de Freund , Glomeruloesclerosis Focal y Segmentaria/inmunología , Glomeruloesclerosis Focal y Segmentaria/metabolismo , Glomeruloesclerosis Focal y Segmentaria/patología , Glomeruloesclerosis Focal y Segmentaria/fisiopatología , Inmunohistoquímica , Glomérulos Renales/inmunología , Glomérulos Renales/metabolismo , Macrófagos/patología , Masculino , Metilcelulosa/farmacología , Fosfatos/metabolismo , Proteinuria/fisiopatología , Conejos , Ratas , Ratas Endogámicas WKY
16.
Pediatr Res ; 43(6): 791-7, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9621989

RESUMEN

Alpha-tocopherol and fish oil have been reported to modulate the progression of IgA nephropathy in animals and humans. Because fish oil has been reported to exacerbate renal disease in subtotal nephrectomized rats, we investigated the effects of fish oil, with and without alpha-tocopherol, on the course of IgA nephropathy. Experimental IgA nephropathy was induced in male Sprague-Dawley rats, weighing 170-200 g, by oral and i.v. immunization with bovine gamma-globulin for 8 wk. IgA nephropathy was evidenced by hematuria, proteinuria, and IgA deposition in the mesangium. Standard rodent chow, containing 30 IU of alpha-tocopherol/kg of diet, was given to the control and IgA nephropathy rats. Fish oil (20% wt/wt), stripped of alpha-tocopherol preservative, was given to control and a second group of IgA nephropathy rats. Alternatively, corn oil or fish oil was supplemented with alpha-tocopherol at 100 IU/kg of diet and given to the third and fourth groups of IgA nephropathy rats. All animals were killed at 8 wk. Urinary protein excretion, plasma and kidney alpha-tocopherol concentrations, as well as glomerular planar area, and kidney transforming growth factor-beta1 mRNA were analyzed. As determined by reductions in proteinuria, glomerular planar area, and TGF-beta1 mRNA, fish oil with alpha-tocopherol ameliorated the renal injury induced by bovine gamma-globulin, whereas fish oil without alpha-tocopherol did not. Our findings support the importance of alpha-tocopherol, more so than fish oil, in mitigating the injury and promoting repair in experimental IgA nephropathy.


Asunto(s)
Aceites de Pescado/farmacología , Glomerulonefritis por IGA/prevención & control , Glomerulonefritis por IGA/fisiopatología , Vitamina E/farmacología , Animales , Bovinos , Grasas de la Dieta , Glomerulonefritis por IGA/patología , Riñón/patología , Glomérulos Renales/inmunología , Glomérulos Renales/patología , Masculino , Nefrectomía , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Transcripción Genética , Factor de Crecimiento Transformador beta/biosíntesis , gammaglobulinas/inmunología
17.
Eur J Biochem ; 239(1): 132-7, 1996 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-8706697

RESUMEN

We present here the complete primary structure of human gp330, the human variant of the principal kidney autoantigen causing Heymann membranous glomerulonephritis in rats. The deduced 4655 amino acid residues give a calculated molecular mass of 519636 Da for the mature protein and consists of a probable 25-amino-acid N-terminal signal peptide sequence, an extracellular region of 4398 amino acids, a single transmembrane-spanning domain of 23 amino acids, and an intracellular C-terminal region of 209 amino acid residues. Three types of cysteine-rich repeats characteristic of the low density lipoprotein receptor (LDLR) superfamily are present in human gp330. In the extracellular region, there are a total of 36 LDLR ligand-binding repeats, comprising four distinct domains, 16 growth factor repeats separated by eight YWTD spacer regions, and one epidermal growth factor-like repeat. No consensus cleavage sequence for the processing endoprotease furin is detected in human gp330. The intracellular tail contains not only two copies of the F(X)NPXY coated-pit mediated internalization signal characteristic of LDLR superfamily members, but also intriguing and potentially functional motifs including several Src-homology 3 recognition motifs, one Src-homology 2 recognition motif for the p85 regulatory subunit of phosphatidylinositol 3-kinase, and additional sites for protein kinase C, casein kinase II and cAMP-/cGMP-dependent protein kinase. There is approximately 77% amino acid identity between human and rat gp330 with minor differences between the extracellular and intracellular regions. Recently gp330 has been implicated in Ca2+ regulation in the parathyroid, the placenta, and the renal tubule, but its overall physiological and pathological role still remains uncertain.


Asunto(s)
Proteínas de Unión al Calcio/genética , Glicoproteínas de Membrana/genética , Transducción de Señal , Secuencia de Aminoácidos , Animales , Proteínas de Unión al Calcio/metabolismo , Clonación Molecular , ADN Complementario , Complejo Antigénico de Nefritis de Heymann , Humanos , Glomérulos Renales/inmunología , Glicoproteínas de Membrana/metabolismo , Datos de Secuencia Molecular , Peso Molecular , Ratas , Homología de Secuencia de Aminoácido , Dominios Homologos src
18.
J Autoimmun ; 8(2): 267-77, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7612152

RESUMEN

Diverse immunologic abnormalities have been described in women who received silicone breast implants. However, most studies have focused on either a limited number of patients or a small panel of autoantibodies. We report the analysis of 20 autoantibodies in 116 women with implants and 134 controls. The patients ranged from 26- to 66-years-old, with a mean of 45.7 +/- 8.3 years; breast prostheses were in place for a mean of 15 +/- 5.6 years, with a range of 4 to 30, the chief complaints of the 116 patients included polyarthralgias, fatigue, myalgias, morning stiffness, and decreased memory. All 250 sera were tested blindly using a panel of 20 autoantigens including SS-A, SS-B, RNP, cardiolipin (CL), collagen types I, II and IV, phosphatidylserine (PS), myeloperoxidase (MPO), sulfatides (sulf), thyroglobulin (TG), gangliosides (GDIa;GM2), proteinase-3 (PR3), Jo-1, Sm, HPRPP-ribosomal phosphate, histones (H2AH2B), Scl-70 and glomerular basement membrane (NC-1). Values from individual patients were considered positive only when greater than 3 SD above the control mean. There was a statistically significant greater frequency of autoantibodies in women with implants for 15 of the 20 autoantigens; these were particularly striking for anti-H2AH2B, HPRPP, SS-A, SS-B, Scl-70, CL, PS, GM2, and NC-1. Many patients harbored several autoantibodies; 20% had four autoantibodies; 8% had six autoantibodies. The association of autoantibodies and implants suggests an adjuvant action of silicon/silicone byproducts.


Asunto(s)
Adyuvantes Inmunológicos , Autoanticuerpos/sangre , Enfermedades Autoinmunes/etiología , Implantes de Mama/efectos adversos , Enfermedades Reumáticas/etiología , Siliconas/efectos adversos , Adulto , Anciano , Especificidad de Anticuerpos , Autoanticuerpos/inmunología , Autoantígenos/inmunología , Enfermedades Autoinmunes/inmunología , Membrana Basal/inmunología , Enfermedades de la Mama , Colágeno/inmunología , Femenino , Geles , Humanos , Glomérulos Renales/inmunología , Persona de Mediana Edad , Poliuretanos , Falla de Prótesis , Enfermedades Reumáticas/inmunología , Método Simple Ciego , Cloruro de Sodio , Tiroglobulina/inmunología , Factores de Tiempo
19.
Nephrol Dial Transplant ; 10(7): 1149-54, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7478116

RESUMEN

Cyclosporin A (CsA) can reduce proteinuria in various forms of human and experimental glomerulonephritis. This antiproteinuric effect of CsA may be the consequence of diminution of immunological damage, a drug-induced decrease of GFR, or changes in permselectivity of the glomerular basement membrane (GBM). We studied the antiproteinuric effect of CsA in the heterologous phase of a passively induced anti-GBM nephritis in the mouse. This passive model is characterized by acute exudative glomerular lesions and a dose-dependent albuminuria. Rabbit anti-mouse GBM antibodies were administered intravenously in C57B110 mice at day 4, after 3 days of pretreatment with either CsA (75 mg/kg body weight) (n = 15) or olive oil (OO, controls, n = 15) orally. CsA did not influence the severity of the histological lesions. Albuminuria was substantially reduced by CsA (CsA 1.6 +/- 1.8; OO 5.6 +/- 3.2 mg/18 h; P < 0.002). There was a considerable concomitant reduction of the GFR by CsA, as measured with a 51Cr-EDTA single-shot plasma clearance technique before (day-1) and during treatment (day 4): GFR ratio day 4/day-1 for CsA, 0.4 +/- 0.1; for OO controls, 1.1 +/- 0.6; P < 0.01. This drug-induced decrease of GFR was prevented by simultaneous treatment with phenoxybenzamine (PB) twice daily 45 micrograms orally for 4 days (GFR ratio day 4/day-1 for PB and CsA, 0.9 +/- 0.4; controls (PB and OO), 1.0 +/- 0.4; P = NS). Although the CsA-induced GFR reduction was prevented, CsA still reduced albuminuria significantly (PB and CsA, 2.2 +/- 1.8; controls (PB and OO), 5.6 +/- 1.8 mg/18 h; P = 0.003).(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Albuminuria/tratamiento farmacológico , Anticuerpos/inmunología , Ciclosporina/uso terapéutico , Tasa de Filtración Glomerular/efectos de los fármacos , Glomérulos Renales/inmunología , Nefritis/inmunología , Animales , Membrana Basal/inmunología , Ratones , Ratones Endogámicos C57BL , Nefritis/patología , Nefritis/orina , Conejos
20.
J Biol Chem ; 269(31): 19953-62, 1994 Aug 05.
Artículo en Inglés | MEDLINE | ID: mdl-7519601

RESUMEN

Podocytes are specialized epithelial cells with delicate interdigitating foot processes which cover the exterior basement membrane surface of the glomerular capillary. They are in part responsible for the extraordinary charge and size filtration characteristics of the glomerulus. To better understand disease processes affecting the glomerular filter, we searched for proteins with relative specificity to the podocyte using a monoclonal antibody strategy. The first such protein characterized (designated glomerular epithelial protein 1 (GLEPP1)) is a membrane protein-tyrosine phosphatase (PTPase) with a large extracellular domain containing eight fibronectin type III-like repeats, a hydrophobic transmembrane segment, and a single PTPase domain. The GLEPP1 PTPase domain shows homology with two other single domain transmembrane PTPases (PTP beta and Drosophila central nervous system PTP10D). This homology includes 2 cysteines in the PTPase domain not present in intracellular or tandem domain membrane PTPases. GLEPP1 PTPase protein is distributed to the podocyte foot processes themselves. RNase protection assay shows that GLEPP1 mRNA is also present in brain. By analogy with the CD45 PTPase of T cells, we expect that this receptor might play a role in maintaining foot process structure and/or function by regulating tyrosine phosphorylation of podocyte proteins.


Asunto(s)
Glomérulos Renales/enzimología , Proteínas de la Membrana/genética , Proteínas Tirosina Fosfatasas/genética , Proteínas Tirosina Fosfatasas/metabolismo , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales , Especificidad de Anticuerpos , Secuencia de Bases , Membrana Celular/enzimología , Clonación Molecular , ADN Complementario , Células Epiteliales , Epitelio/enzimología , Epitelio/inmunología , Epítopos , Humanos , Glomérulos Renales/citología , Glomérulos Renales/inmunología , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , ARN Mensajero/genética , ARN Mensajero/metabolismo , Conejos , Proteínas Tirosina Fosfatasas Clase 3 Similares a Receptores , Homología de Secuencia de Aminoácido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA